DiscoverTreating Blood CancersAdvancing Treatment Strategies: The Role of Bispecific Antibodies in Lymphoma
Advancing Treatment Strategies: The Role of Bispecific Antibodies in Lymphoma

Advancing Treatment Strategies: The Role of Bispecific Antibodies in Lymphoma

Update: 2024-12-19
Share

Description





Celeste Bello, MD, Moffitt Cancer Center, Tampa, FL

























Recorded on November 21, 2024











Celeste Bello, MD

Senior Member, Department of Malignant Hematology

Moffitt Cancer Center

Tampa, FL









Join us as we dive into bispecific antibodies with Dr. Celeste Bello from Moffitt Cancer Center, exploring their mechanisms of action, current indications in lymphoma, and strategies for patient selection and administration. Dr. Bello also discusses side effects, management strategies, and emerging trends in bispecific therapies. Tune in today to learn more!






















Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Advancing Treatment Strategies: The Role of Bispecific Antibodies in Lymphoma

Advancing Treatment Strategies: The Role of Bispecific Antibodies in Lymphoma

Blood Cancer United